Intensity Therapeutics, Inc.
INTS
$0.282
-$0.009-3.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.22M | 929.00K | 2.59M | 2.78M | 6.32M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 822.00K | 722.00K | 773.00K | 1.01M | 1.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.04M | 1.65M | 3.36M | 3.79M | 7.44M |
|
|
|||||
| Total Current Assets | 3.04M | 1.65M | 3.36M | 3.79M | 7.44M |
| Net Property, Plant & Equipment | 109.00K | 116.00K | 122.00K | 128.00K | 135.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.30M | 1.30M | 1.30M | 1.30M | 1.10M |
| Total Assets | 4.44M | 3.07M | 4.78M | 5.21M | 8.67M |
|
|
|||||
| Total Accounts Payable | 1.19M | 1.59M | 1.22M | 540.00K | 1.92M |
| Total Accrued Expenses | 941.00K | 1.01M | 508.00K | 1.75M | 1.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 30.00K | 29.00K | 28.00K | 28.00K | 27.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.16M | 2.63M | 1.76M | 2.32M | 3.20M |
|
|
|||||
| Total Current Liabilities | 2.16M | 2.63M | 1.76M | 2.32M | 3.20M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 95.00K | 102.00K | 110.00K | 117.00K | 124.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.26M | 2.73M | 1.87M | 2.43M | 3.33M |
|
|
|||||
| Common Stock & APIC | 74.85M | 70.46M | 69.70M | 66.38M | 65.43M |
| Retained Earnings | -72.67M | -70.13M | -66.78M | -63.60M | -60.09M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.18M | 334.00K | 2.92M | 2.78M | 5.35M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.18M | 334.00K | 2.92M | 2.78M | 5.35M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.18M | 334.00K | 2.92M | 2.78M | 5.35M |
|
|
|||||